|
|
|
Substance Name: Cefaclor [INN]
RN: 53994-73-3
UNII: 3Z6FS3IK0K
InChIKey: QYIYFLOTGYLRGG-GPCCPHFNSA-N
Note
- Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN.
Molecular Formula
- C15-H14-Cl-N3-O4-S
Molecular Weight
- 367.8116
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Structure Descriptors
- Toxicity
- Physical Properties
Classification Codes
- Anti-Bacterial Agents
- Anti-Infective Agents
- Drug / Therapeutic Agent
- Human Data
- Reproductive Effect
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Regulatory Agencies (Superlist Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Results Name
- Cefaclor [INN]
Name of Substance
- Cefaclor anhydrous
- Cefaclor [INN]
MeSH Heading
- Cefaclor
Synonyms
- (6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
- 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid
- Ceclor
- Ceclor CD
- Cefaclor
- Cefaclorum
- Cefaclorum [INN-Latin]
- Cephaclor
- EINECS 258-909-5
- Kefral
- Lilly 99638
- Panoral
- Raniclor
- S 6472
- UNII-3Z6FS3IK0K
Systematic Names
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6-alpha,7-beta(R*)))-
- Cefaclor
Registry Numbers
CAS Registry Number
- 53994-73-3
FDA UNII
- 3Z6FS3IK0K
System Generated Number
- 0053994733
Structure Descriptors
InChI
InChI=1S/C15H14ClN3O4S/c16-8-6-24-14-10(13(21)19(14)11(8)15(22)23)18-12(20)9(17)7-4-2-1-3-5-7/h1-5,9-10,14H,6,17H2,(H,18,20)(H,22,23)/t9-,10-,14-/m1/s1InChIKey
QYIYFLOTGYLRGG-GPCCPHFNSA-NSmiles
N[C@@H](C(=O)Toxicity
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| child | TDLo | oral | 131mg/kg/7D-I (131mg/kg) | MUSCULOSKELETAL: JOINTS SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Canadian Medical Association Journal. Vol. 126, Pg. 1032, 1982. |
| infant | TDLo | oral | 525mg/kg/7D-I (525mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Canadian Medical Association Journal. Vol. 126, Pg. 1032, 1982. |
| mouse | LD50 | intraperitoneal | 1227mg/kg (1227mg/kg) | SKIN AND APPENDAGES (SKIN): HAIR: OTHER BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) | Chemotherapy Vol. 27(Suppl, |
| mouse | LD50 | oral | > 20gm/kg (20000mg/kg) | Chemotherapy Vol. 27(Suppl, | |
| mouse | LD50 | oral | > 20gm/kg (20000mg/kg) | SKIN AND APPENDAGES (SKIN): HAIR: OTHER BEHAVIORAL: ATAXIA | Chemotherapy Vol. 27(Suppl, |
| mouse | LD50 | subcutaneous | 4180mg/kg (4180mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Chemotherapy Vol. 27(Suppl, |
| rat | LD50 | intraperitoneal | 1259mg/kg (1259mg/kg) | SKIN AND APPENDAGES (SKIN): HAIR: OTHER BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) | Chemotherapy Vol. 27(Suppl, |
| rat | LD50 | oral | > 20gm/kg (20000mg/kg) | Chemotherapy Vol. 27(Suppl, | |
| rat | LD50 | oral | > 20gm/kg (20000mg/kg) | SKIN AND APPENDAGES (SKIN): HAIR: OTHER BEHAVIORAL: ATAXIA | Chemotherapy Vol. 27(Suppl, |
| rat | LD50 | subcutaneous | 4838mg/kg (4838mg/kg) | SKIN AND APPENDAGES (SKIN): HAIR: OTHER BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) | Chemotherapy Vol. 27(Suppl, |
Physical Properties
| Physical Property | Value | Units | Temp (deg C) | Source |
|---|---|---|---|---|
| log P (octanol-water) | 0.350 | (none) | EST | |
| Water Solubility | 1.00E+04 | mg/L | EXP | |
| Atmospheric OH Rate Constant | 1.35E-10 | cm3/molecule-sec | 25 | EST |
Physical property data is provided to ChemIDplus by SRC, Inc.